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Introduction
NICR Methods of working
THE MEASUREMENTS OF RARE CANCERS
Anna Gavin, Colin Fox. Sinead Lardener, Eileen Morgan
Northern Ireland Cancer Registry. Queens University Belfast - contact nicr@qub.ac.uk. 
The N. Ireland Cancer Registry founded in 1994 provides information on cancers and pre-malignant disease occurring in Northern Ireland for
research, education, service monitoring and planning. It collects morphology codes using international classifications and has data on
pathologically diagnosed rare tumours which arise in non-rare anatomical sites. E.g. Anaplastic carcinoma of the thyroid.
Statistics
From 2011 to 2015, on average, there were 4,557 male and 4,516 female patients diagnosed with cancer each year excluding Non-Melanoma 
Skin Cancer (NMSC). There were an additional 2,065 male and 1,576 female patients diagnosed with NMSC. Included in this total are many 
rare cancers usually categorised as ‘other’ amounting to approximately 1200 cases per year , some examples of these , their codes and 
number of cases is below . See www.qub.ac.uk/nicr for details of outputs from the registry .
The registry provides a secure confidential environment for the storage and analysis of the
sensitive clinical data having received ISO 27001 accreditation. It has links with the NI
biobank facilitating the collection of clinical details on biological samples
Site ICD 10 code Morphology Average number 
per year*
Hepatocellular carcinoma of liver 
and intrahepatic bile tract (IBT)
C22 8170-8175, 8180 172
Chronic myeloid leukaemia C92.1, C92.2 9863, 9875 15
Mixed epithelial and 
mesenchymal tumours of the 
uterus
C53.0-C55.9 8933,8950-8951, 8980 13
Epithelial tumours of nasal cavity 
and sinuses
C30.0-C31 8000, 8001, 8004, 8010, 8011, 8020-8022, 8032, 8050-8076, 
80878, 8082-8084, 8123, 8144, 8560, 8980
8
Gastrointestional stromal 
sarcoma
Any 8936 5
Malignant melanoma of uvea C69.3-C69.4 8720-8780 3
Kaposi’s sarcoma Any 9140 2
Malignant meningiomas C70 9530, 9538-9539 1
Work is ongoing at European and international level to standardise 
recording and categorisation of these rare tumours and to combine 
datasets from many countries to enable epidemiological and scientific 
study including   Joint Action on Rare cancers work package 4 - Improving 
epidemiological surveillance on rare cancers in Europe.
The N. Ireland Cancer Registry is funded by the Public Health Agency for Northern Ireland. 
